» Articles » PMID: 10350018

Microdialysis Evaluation of the Ocular Pharmacokinetics of Propranolol in the Conscious Rabbit

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1999 Jun 1
PMID 10350018
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study was conducted to assess the effects of anesthesia and aqueous humor protein concentrations on ocular disposition of propranolol.

Methods: Rabbits were anesthetized and a microdialysis probe was inserted into the anterior chamber of one eye; the contralateral eye served as a control. At timed intervals after probe placement, a 100-microl sample of aqueous humor was aspirated from each eye to determine protein concentration. In vitro protein binding parameters were used to simulate the impact of protein concentration on propranolol disposition. To assess the influence of anesthesia, probes were implanted in the anterior chamber of each eye. After >5-day stabilization, conscious and anesthetized rabbits (n = 3/group) received a 200-microg topical dose of [3H]DL-propranolol in each eye; propranolol was assayed in probe effluent.

Results: Changes in aqueous humor protein concentrations were observed following probe insertion. Simulations demonstrated that the unbound propranolol AUC (approximately 2.4-fold) in aqueous humor should be reduced due to protein influx. Intraocular propranolol exposure in anesthetized rabbits was approximately 8-fold higher than in conscious rabbits, and approximately 1.9-fold higher than in rabbits without a post-surgical recovery period.

Conclusions: Anesthesia and time-dependent aqueous humor protein concentrations may alter ocular pharmacokinetics, and must be taken into account in the design of microdialysis experiments.

Citing Articles

Drug and gene delivery to the back of the eye: from bench to bedside.

Rowe-Rendleman C, Durazo S, Kompella U, Rittenhouse K, Di Polo A, Weiner A Invest Ophthalmol Vis Sci. 2014; 55(4):2714-30.

PMID: 24777644 PMC: 4004426. DOI: 10.1167/iovs.13-13707.


Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals.

Janoria K, Boddu S, Natesan S, Mitra A J Ocul Pharmacol Ther. 2010; 26(3):265-71.

PMID: 20565313 PMC: 2974849. DOI: 10.1089/jop.2009.0123.


Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.

Kaur I, Aggarwal D, Singh H, Kakkar S Graefes Arch Clin Exp Ophthalmol. 2010; 248(10):1467-72.

PMID: 20437246 DOI: 10.1007/s00417-010-1383-0.

References
1.
Hussain A, Hirai S, Sieg J . Ocular absorption of propranolol in rabbits. J Pharm Sci. 1980; 69(6):738-9. DOI: 10.1002/jps.2600690637. View

2.
Tahery M, Lee D . Review: pharmacologic control of wound healing in glaucoma filtration surgery. J Ocul Pharmacol. 1989; 5(2):155-79. DOI: 10.1089/jop.1989.5.155. View

3.
Latour E, Driot J, Coquelet C, Bonne C . The role of platelets in blood-aqueous barrier breakdown induced by anterior chamber paracentesis in the rabbit. Curr Eye Res. 1989; 8(11):1105-10. DOI: 10.3109/02713688909000035. View

4.
Rittenhouse K, Peiffer Jr R, Pollack G . Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J Pharm Biomed Anal. 1998; 16(6):951-9. DOI: 10.1016/s0731-7085(97)00060-5. View

5.
Louzada-Junior P, Dias J, Santos W, Lachat J, Bradford H, Coutinho-Netto J . Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem. 1992; 59(1):358-63. DOI: 10.1111/j.1471-4159.1992.tb08912.x. View